Clinical Trials List
2019-06-01 - 2025-12-31
Phase III
Recruiting4
ICD-10C73
Malignant neoplasm of thyroid gland
ICD-10E31.22
Multiple endocrine neoplasia [MEN] type IIA
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9193
Malignant neoplasm of thyroid gland
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 呂金盈 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 施翔蓉 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Hung Chen 無
- 洪崇傑醫師 無
- Liu Yi-Sheng 無
- Li-Tzong Chen 無
- 洪崇傑醫師 無
- 洪崇傑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
400 participants
